176 related articles for article (PubMed ID: 20394697)
41. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness of health education to increase screening for cervical cancer among eastern-band Cherokee Indian women in North Carolina.
Dignan M; Michielutte R; Blinson K; Wells HB; Case LD; Sharp P; Davis S; Konen J; McQuellon RP
J Natl Cancer Inst; 1996 Nov; 88(22):1670-6. PubMed ID: 8931612
[TBL] [Abstract][Full Text] [Related]
43. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
Hewitt M; Devesa SS; Breen N
Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
[TBL] [Abstract][Full Text] [Related]
45. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
[TBL] [Abstract][Full Text] [Related]
46. Barriers and facilitators to anal cancer screening among people living with HIV in Puerto Rico.
Cruz G; Ramos-Cartagena JM; Torres-Russe JL; Colón-López V; Ortiz-Ortiz KJ; Pericchi L; Deshmukh AA; Ortiz AP
BMC Public Health; 2023 Oct; 23(1):1940. PubMed ID: 37803344
[TBL] [Abstract][Full Text] [Related]
47. Community-based cultural predictors of Pap smear screening in Nova Scotia.
Johnston GM; Boyd CJ; MacIsaac MA
Can J Public Health; 2004; 95(2):95-8. PubMed ID: 15074897
[TBL] [Abstract][Full Text] [Related]
48. Physician recommendation for papanicolaou testing among U.S. women, 2000.
Coughlin SS; Breslau ES; Thompson T; Benard VB
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
[TBL] [Abstract][Full Text] [Related]
49. Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women.
Llanos AAM; Tsui J; Rotter D; Toler L; Stroup AM
BMC Womens Health; 2018 Oct; 18(1):162. PubMed ID: 30285820
[TBL] [Abstract][Full Text] [Related]
50. Surveillance of certain health behaviors and conditions among states and selected local areas--Behavioral Risk Factor Surveillance System (BRFSS), United States, 2006.
Kilmer G; Roberts H; Hughes E; Li Y; Valluru B; Fan A; Giles W; Mokdad A; Jiles R;
MMWR Surveill Summ; 2008 Aug; 57(7):1-188. PubMed ID: 18701879
[TBL] [Abstract][Full Text] [Related]
51. Pap smear receipt among Vietnamese immigrants: the importance of health care factors.
Taylor VM; Yasui Y; Nguyen TT; Woodall E; Do HH; Acorda E; Li L; Choe J; Jackson JC
Ethn Health; 2009 Dec; 14(6):575-89. PubMed ID: 19626504
[TBL] [Abstract][Full Text] [Related]
52. Is Immigrant Status Associated With Cervical Cancer Screening Among Women in Canada? Results From a Cross-Sectional Study.
Bacal V; Blinder H; Momoli F; Wu KY; McFaul S
J Obstet Gynaecol Can; 2019 Jun; 41(6):824-831.e1. PubMed ID: 30361160
[TBL] [Abstract][Full Text] [Related]
53. Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995-2006.
McCarthy AM; Dumanovsky T; Visvanathan K; Kahn AR; Schymura MJ
Cancer Causes Control; 2010 Oct; 21(10):1645-55. PubMed ID: 20521091
[TBL] [Abstract][Full Text] [Related]
54. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
[TBL] [Abstract][Full Text] [Related]
55. Never Screened: Understanding Breast Cancer Nonadherence in Puerto Rico.
Ayala-Marín AM; Colón-López V; Vélez-Álamo C; Fernández-Espada N; Pattatucci A; Fernández ME
Health Educ Behav; 2021 Oct; 48(5):559-566. PubMed ID: 33666106
[TBL] [Abstract][Full Text] [Related]
56. Race and ethnic disparities in cervical cancer screening in a safety-net system.
Owusu GA; Eve SB; Cready CM; Koelln K; Trevino F; Urrutia-Rojas X; Baumer J
Matern Child Health J; 2005 Sep; 9(3):285-95. PubMed ID: 16163439
[TBL] [Abstract][Full Text] [Related]
57. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
58. Knowledge about cervical cancer, Pap test, and barriers to women's participation in screening in Belgrade, Serbia.
Jovanovic V; Mitrovic Jovanovic A; Zivanovic A; Kocic S; Vasiljevic M; Krasic V
Eur J Gynaecol Oncol; 2017; 38(1):69-75. PubMed ID: 29767868
[TBL] [Abstract][Full Text] [Related]
59. Factors associated with cervical cancer screening behavior among Vietnamese women.
Yi JK
J Community Health; 1994 Jun; 19(3):189-200. PubMed ID: 8089269
[TBL] [Abstract][Full Text] [Related]
60. Cervical and Breast Cancer Screening Among Mexican Migrant Women, 2013.
Guerrero N; Zhang X; Rangel G; Gonzalez-Fagoaga JE; Martinez-Donate A
Prev Chronic Dis; 2016 Aug; 13():E104. PubMed ID: 27513995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
